Puma Biotechnology, Inc. Profile Avatar - Palmy Investing

Puma Biotechnology, Inc.

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the pati…

Biotechnology
US, Los Angeles [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Puma Biotechnology, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Puma Biotechnology, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Puma Biotechnology, Inc..

End of PBYI's Analysis
CIK: 1401667 CUSIP: 74587V107 ISIN: US74587V1070 LEI: - UEI: -
Secondary Listings
PBYI has no secondary listings inside our databases.